Axcella Health Inc. (AXLA)

Exchange NASDAQ
1.96


Currency in USD (Disclaimer)
Volume:
Day's Range:

AXLA Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-01 Koziel Margaret officer: Chief Medical Officer 26,109.0 S-Sale D 590.0 2.01 1,186.31
2022-05-19 Epstein David R director 209,756.0 A-Award A 47,059.0 0.00 0.00
2022-05-19 SEKHRI PAUL J director 40,000.0 A-Award A 40,000.0 1.70 68,000.00
2022-05-19 Hendrix Martin director 40,000.0 A-Award A 40,000.0 1.70 68,000.00
2022-05-19 Sohn Catherine A. director 20,000.0 A-Award A 20,000.0 1.70 34,000.00
2022-05-19 Baird William D III director 20,000.0 A-Award A 20,000.0 1.70 34,000.00
2022-05-19 Rondinone CRISTINA director 20,000.0 A-Award A 20,000.0 1.70 34,000.00
2022-05-19 Rosenblatt Michael director 40,000.0 A-Award A 40,000.0 1.70 68,000.00
2022-05-19 Pisano Gary P. director 20,000.0 A-Award A 20,000.0 1.70 34,000.00
2022-03-18 Epstein David R director 0.0 M-Exempt D 1,535.0 0.00 0.00
2022-03-18 Epstein David R director 50,000.0 A-Award D 50,000.0 2.51 125,500.00
2022-03-18 Epstein David R director 162,697.0 M-Exempt A 1,535.0 0.00 0.00
2022-03-16 Crane Robert officer: Chief Financial Officer 125,000.0 A-Award A 125,000.0 1.63 203,750.00
2022-03-16 Flagship Ventures Fund IV General Partner LLC 10 percent owner 4,465,866.0 P-Purchase A 1,579,843.0 1.91 3,017,500.13
2022-03-16 Flagship Ventures Fund IV General Partner LLC 10 percent owner 2,004,657.0 P-Purchase A 947,905.0 1.91 1,810,498.55
2022-03-16 Flagship Ventures Fund IV General Partner LLC 10 percent owner 8,600,403.0 P-Purchase A 3,791,623.0 1.91 7,241,999.93
2022-03-16 Crane Robert officer: Chief Financial Officer 39,267.0 P-Purchase A 39,267.0 1.91 74,999.97
2022-03-16 Epstein David R director 161,162.0 P-Purchase A 26,178.0 1.91 49,999.98
2022-03-16 Fehlner Paul officer: SVP & Chief Legal Officer 20,802.0 P-Purchase A 10,471.0 1.91 19,999.61
2022-03-16 Hinshaw William director, officer: President & CEO 48,012.0 P-Purchase A 13,089.0 1.91 24,999.99
2022-03-16 Societe des Produits Nestle S.A. 10 percent owner 7,446,902.0 P-Purchase A 3,141,361.0 1.91 5,999,999.51
2022-03-01 Koziel Margaret officer: Chief Medical Officer 26,699.0 S-Sale D 553.0 1.86 1,029.58
2022-02-18 Epstein David R director 1,535.0 M-Exempt D 1,534.0 0.00 0.00
2022-02-18 Epstein David R director 134,984.0 M-Exempt A 1,534.0 0.00 0.00
2022-02-08 Fehlner Paul officer: SVP & Chief Legal Officer 70,000.0 A-Award A 70,000.0 1.63 114,100.00
2022-02-08 Schecter Alison D. officer: President - Research & Dev. 56,000.0 A-Award A 56,000.0 1.63 91,280.00
2022-02-08 Hinshaw William director, officer: President & CEO 100,000.0 A-Award A 100,000.0 5.00 500,000.00
2022-02-08 Hinshaw William director, officer: President & CEO 275,000.0 A-Award A 275,000.0 1.63 448,250.00
2022-02-08 Koziel Margaret officer: Chief Medical Officer 33,397.0 A-Award A 33,397.0 1.63 54,437.11
2022-02-08 Dean Virginia R officer: SVP, Chief People Officer 71,400.0 A-Award A 71,400.0 1.63 116,382.00
2022-01-31 Hinshaw William director, officer: President and CEO 0.0 M-Exempt D 50,000.0 0.00 0.00
2022-01-31 Hinshaw William director, officer: President and CEO 33,410.0 S-Sale D 16,590.0 1.65 27,393.41
2022-01-28 Hinshaw William director, officer: President and CEO 50,000.0 M-Exempt A 50,000.0 0.00 0.00
2022-01-18 Epstein David R director 3,069.0 M-Exempt D 1,535.0 0.00 0.00
2022-01-18 Epstein David R director 133,450.0 M-Exempt A 1,535.0 0.00 0.00
2021-12-17 Epstein David R director 4,604.0 M-Exempt D 1,535.0 0.00 0.00
2021-12-17 Epstein David R director 131,915.0 M-Exempt A 1,535.0 0.00 0.00
2021-12-10 Schecter Alison D. officer: President - Research & Dev. 25,000.0 A-Award A 25,000.0 5.57 139,250.00
2021-12-10 Koziel Margaret officer: Chief Medical Officer 75,000.0 A-Award A 75,000.0 2.60 195,000.00
2021-11-18 Epstein David R director 6,139.0 M-Exempt D 1,534.0 0.00 0.00
2021-11-18 Epstein David R director 130,380.0 M-Exempt A 1,534.0 0.00 0.00
2021-10-18 Epstein David R director 7,673.0 M-Exempt D 1,535.0 0.00 0.00
2021-10-18 Epstein David R director 128,846.0 M-Exempt A 1,535.0 0.00 0.00
2021-09-17 Epstein David R director 127,311.0 M-Exempt A 1,535.0 0.00 0.00
2021-09-17 Epstein David R director 9,208.0 M-Exempt D 1,535.0 0.00 0.00
2021-08-18 Epstein David R director 125,776.0 M-Exempt A 1,534.0 0.00 0.00
2021-08-18 Epstein David R director 10,743.0 M-Exempt D 1,534.0 0.00 0.00
2021-08-13 Pisano Gary P. director 81,433.0 M-Exempt A 81,433.0 0.28 22,801.24
2021-08-13 Pisano Gary P. director 0.0 M-Exempt D 81,433.0 0.28 22,801.24
2021-07-16 Epstein David R director 124,242.0 M-Exempt A 1,535.0 0.00 0.00
2021-07-16 Epstein David R director 12,277.0 M-Exempt D 1,535.0 0.00 0.00
2021-06-22 Dean Virginia R officer: SVP, Chief People Officer 140,000.0 A-Award A 140,000.0 4.15 581,000.00
2021-06-18 Epstein David R director 13,812.0 M-Exempt D 1,535.0 0.00 0.00
2021-06-18 Epstein David R director 122,707.0 M-Exempt A 1,535.0 0.00 0.00
2021-05-20 Hoge Stephen director 20,000.0 A-Award A 20,000.0 3.24 64,800.00
2021-05-20 Behar Gregory director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-20 Pisano Gary P. director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-20 Rondinone CRISTINA director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-20 Baird William D III director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-20 Aradhye Shreeram director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-20 Sohn Catherine A. director 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-05-18 Epstein David R director 15,347.0 M-Exempt D 1,534.0 0.00 0.00
2021-05-18 Epstein David R director 121,172.0 M-Exempt A 1,534.0 0.00 0.00
2021-04-18 Epstein David R director 16,881.0 M-Exempt D 1,535.0 0.00 0.00
2021-04-18 Epstein David R director 119,638.0 M-Exempt A 1,535.0 0.00 0.00
2021-03-18 Epstein David R director 120,000.0 A-Award A 120,000.0 0.00 0.00
2021-03-18 Epstein David R director 18,416.0 A-Award A 18,416.0 0.00 0.00
2021-03-17 Schecter Alison D. officer: President - Research & Dev. 250,000.0 A-Award A 250,000.0 5.57 1,392,500.00
2021-02-09 Fehlner Paul officer: SVP and Chief Legal Officer 42,500.0 A-Award A 42,500.0 0.00 0.00
2021-02-09 Chakravarthy Manu officer: SVP & Chief Medical Officer 102,000.0 A-Award A 102,000.0 0.00 0.00
2021-02-09 Hinshaw William director, officer: President and CEO 375,000.0 A-Award A 375,000.0 0.00 0.00
2021-02-09 Fehlner Paul officer: SVP and Chief Legal Officer 85,000.0 A-Award A 85,000.0 0.00 0.00
2021-02-09 Chardonnet Laurent officer: Chief Financial Officer 120,000.0 A-Award A 120,000.0 0.00 0.00
2021-02-09 Chardonnet Laurent officer: Chief Financial Officer 25,000.0 A-Award A 25,000.0 0.00 0.00
2021-02-09 Chardonnet Laurent officer: Chief Financial Officer 60,000.0 A-Award A 60,000.0 0.00 0.00
2021-02-01 Chakravarthy Manu officer: SVP & Chief Medical Officer 60,000.0 M-Exempt A 60,000.0 0.00 0.00
2021-02-01 Chakravarthy Manu officer: SVP & Chief Medical Officer 41,528.0 S-Sale D 18,472.0 5.50 101,631.10
2020-10-30 Chardonnet Laurent officer: Chief Financial Officer 6,266.0 A-Award A 2,601.0 0.00 0.00
2020-09-29 Hinshaw William director, officer: President and CEO 50,000.0 A-Award A 50,000.0 0.00 0.00
2020-09-16 Fehlner Paul officer: SVP and Chief Legal Officer 30,000.0 A-Award A 30,000.0 0.00 0.00
2020-09-08 Societe des Produits Nestle S.A. 10 percent owner 4,305,541.0 J-Other A 4,305,541.0 4.42 19,030,491.22
2020-09-01 Aradhye Shreeram director 22,000.0 A-Award A 22,000.0 4.89 107,580.00
2020-08-01 Chakravarthy Manu officer: SVP & Chief Medical Officer 60,000.0 A-Award A 60,000.0 0.00 0.00
2020-06-05 Epstein David R director 6,800.0 A-Award A 6,800.0 0.00 0.00
2020-05-20 Epstein David R director 65,000.0 A-Award A 65,000.0 0.00 0.00
2020-05-20 Behar Gregory director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Hoge Stephen director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Pisano Gary P. director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Rondinone CRISTINA director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Sohn Catherine A. director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Baird William D III director 11,000.0 A-Award A 11,000.0 0.00 0.00
2020-05-20 Epstein David R director 35,000.0 A-Award A 35,000.0 0.00 0.00
2020-05-18 Epstein David R director 118,103.0 P-Purchase A 50,000.0 4.75 237,500.00
2020-05-18 Nestle Health Science US Holdings, Inc. 10 percent owner 4,305,541.0 P-Purchase A 1,936,842.0 0.00 0.00
2020-05-18 Flagship Ventures Fund IV General Partner LLC 10 percent owner 4,808,780.0 P-Purchase A 1,520,000.0 4.75 7,220,000.00
2020-05-18 Flagship Ventures Fund IV General Partner LLC 10 percent owner 1,056,752.0 P-Purchase A 380,000.0 4.75 1,805,000.00
2020-05-18 Flagship Ventures Fund IV General Partner LLC 10 percent owner 2,886,023.0 P-Purchase A 1,900,000.0 4.75 9,025,000.00
2020-02-28 Epstein David R director 68,103.0 P-Purchase A 2,005.0 3.75 7,518.75
2020-02-27 Epstein David R director 66,098.0 P-Purchase A 12,800.0 3.65 46,720.00
2020-01-31 Chardonnet Laurent officer: Chief Financial Officer 3,665.0 P-Purchase A 3,000.0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.